Replies to post #215726 on Elite Pharmaceuticals Inc (ELTP)

[mrwrn2010]

So just so we're clear:

It was a labeling issue in 2014 when Elite ran the BE trial.
It was a labeling issue in 2015.
It was a labeling issue early and mid 2016 when Elite filed and discussed the data with the FDA, which then accepted the NDA as ready for review.
It metamorphosed into a safety issue the week of July 11th.

Mmmmmmk SOUNDS LEGIT. LOL!!!!!